Stephens Begins Coverage on Definitive Healthcare (NASDAQ:DH)

Stephens assumed coverage on shares of Definitive Healthcare (NASDAQ:DH - Free Report) in a report released on Friday, Marketbeat.com reports. The brokerage issued an equal weight rating and a $5.00 price objective on the stock.

Other research analysts have also issued research reports about the stock. BTIG Research assumed coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a "buy" rating and a $7.00 target price for the company. Needham & Company LLC restated a "hold" rating on shares of Definitive Healthcare in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $5.72.

Definitive Healthcare Stock Performance

DH stock traded up $0.04 during midday trading on Friday, hitting $4.18. 852,709 shares of the company traded hands, compared to its average volume of 720,932. The business has a 50 day simple moving average of $4.42 and a 200-day simple moving average of $4.70. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a twelve month low of $3.19 and a twelve month high of $10.62. The stock has a market capitalization of $482.89 million, a price-to-earnings ratio of -1.35, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40.

Insiders Place Their Bets

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company's stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 14.84% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Point72 DIFC Ltd grew its holdings in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after acquiring an additional 8,215 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of Definitive Healthcare during the third quarter valued at approximately $55,000. Bleakley Financial Group LLC acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $74,000. Glenmede Trust Co. NA lifted its holdings in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after buying an additional 5,362 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new position in Definitive Healthcare during the 3rd quarter worth $84,000. 98.67% of the stock is owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.